Abstract
Biodegradable polymers for focal drug delivery application play both structural and functional roles. Delivery via these biodegradable polymeric carriers is one of the simplest and most successful approaches due to its physicochemical properties and biocompatibility of these polymers. Thus, these polymers have been increasingly used as implants, invasive delivery systems, and to deliver drugs to a specific site or body compartment. Biodegradable materials used in clinically tested for focal drug therapy are both from natural origin (gelatin, collagen, hyaluronic acid, etc.) and synthetic origin (prepared from lactic acid, glycolic acid, caprolactone, etc.). This chapter provides a review of both introductory and state-of-the-art information about the polymeric carriers used in focal drug therapy for diseased states that are most exploited for localized treatment.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Jain JP, Yenet Ayen W, Domb AJ, Kumar N (2011) Biodegradable polymers in clinical use and clinical development. Wiley, Hoboken, NJ, pp 1–58
Mittal A, Chitkara D, Kumar N, Pawar R, Domb A, Corn B (2007) Polymeric Carriers for Regional Drug Therapy, Smart polymers. CRC, Boca Raton, FL, pp 359–400
Dang JM, Leong KW (2006) Natural polymers for gene delivery and tissue engineering. Adv Drug Deliv Rev 58(4):487–499
Lee CH, Singla A, Lee Y (2001) Biomedical applications of collagen. Int J Pharm 221(1–2):1–22
Capito RM, Spector M (2007) Collagen scaffolds for nonviral IGF-1 gene delivery in articular cartilage tissue engineering. Gene Ther 14(9):721–732
Eliopoulos N, Lejeune L, Martineau D, Galipeau J (2004) Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells. Mol Ther 10(4):741–748
Aishwarya S, Mahalakshmi S, Sehgal PK (2008) Collagen-coated polycaprolactone microparticles as a controlled drug delivery system. J Microencapsul 25(5):298–306
Ananta M, Aulin CE, Hilborn J, Aibibu D, Houis S, Brown RA, Mudera V (2009) A poly(lactic acid-co-caprolactone)-collagen hybrid for tissue engineering applications. Tissue Eng Part A 15(7):1667–1675
Beier JP, Klumpp D, Rudisile M, Dersch R, Wendorff JH, Bleiziffer O, Arkudas A, Polykandriotis E, Horch RE, Kneser U (2009) Collagen matrices from sponge to nano: new perspectives for tissue engineering of skeletal muscle. BMC Biotechnol 9:34
Duan X, McLaughlin C, Griffith M, Sheardown H (2007) Biofunctionalization of collagen for improved biological response: scaffolds for corneal tissue engineering. Biomaterials 28:78–88
Becker C, Olde Damink L, Laeufer T, Brehmer B, Heschel I, Jakse G (2006) ‘UroMaix’ scaffolds: novel collagen matrices for application in tissue engineering of the urinary tract. Int J Artif Organs 29(8):764–771
Khan W, Yadav D, Domb AJ, Kumar N (2011) Biodegradable polymers in clinical use and clinical development. Wiley, Hoboken, NJ, pp 59–89
Cai S, Zhai Y, Xu G, Lu S, Zhou W, Ye X (2011) Preparation and properties of calcium phosphate cements incorporated gelatin microspheres and calcium sulfate dihydrate as controlled local drug delivery system. J Mater Sci Mater Med 22(11):2487–2496
Samad A, Sultana Y, Khar RK, Chuttani K, Mishra AK (2009) Gelatin microspheres of rifampicin cross-linked with sucrose using thermal gelation method for the treatment of tuberculosis. J Microencapsul 26(1):83–89
Cao FL, Xi YW, Tang L, Yu AH, Zhai GX (2009) Preparation and characterization of curcumin loaded gelatin microspheres for lung targeting. Zhong Yao Cai 32(3):423–426
Ohta S, Nitta N, Sonoda A, Seko A, Tanaka T, Takahashi M, Kimura Y, Tabata Y, Murata K (2009) Cisplatin-conjugated degradable gelatin microspheres: fundamental study in vitro. Br J Radiol 82(977):380–385
Featherstone C (1997) Fibrin sealants for haemostasis and drug delivery. Lancet 349(9048):334
Greco F, de Palma L, Spagnolo N, Rossi A, Specchia N, Gigante A (1991) Fibrin-antibiotic mixtures: an in vitro study assessing the possibility of using a biologic carrier for local drug delivery. J Biomed Mater Res 25(1):39–51
Cruysberg LP, Nuijts RM, Gilbert JA, Geroski DH, Hendrikse F, Edelhauser HF (2005) In vitro sustained human transscleral drug delivery of fluorescein-labeled dexamethasone and methotrexate with fibrin sealant. Curr Eye Res 30(8):653–660
Miyazaki S, Ishii K, Takada M (1982) Use of fibrin film as a carrier for drug delivery: a long-acting delivery system for pilocarpine into the eye. Chem Pharm Bull (Tokyo) 30(9):3405–3407
Senderoff RI, Sheu MT, Sokoloski TD (1991) Fibrin based drug delivery systems. J Parenter Sci Technol 45(1):2–6
Kupcsik L, Alini M, Stoddart MJ (2009) Epsilon-aminocaproic acid is a useful fibrin degradation inhibitor for cartilage tissue engineering. Tissue Eng Part A 15(8):2309–2313
Sugitachi A, Takatsuka Y, Numata N, Kawahara T, Hirata M, Kido T, Sakamoto I (1989) Loco-regional cancer chemotherapy with a new drug delivery system, “anticancer drug-fibrin clot”. Gan To Kagaku Ryoho 16(8 Pt 2):2814–2817
Ahmed TA, Dare EV, Hincke M (2008) Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 14(2):199–215
Breen A, Dockery P, O’Brien T, Pandit A (2009) Fibrin scaffold promotes adenoviral gene transfer and controlled vector delivery. J Biomed Mater Res A 89(4):876–884
Mol A, van Lieshout MI, Dam-de Veen CG, Neuenschwander S, Hoerstrup SP, Baaijens FP, Bouten CV (2005) Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials 26(16):3113–3121
Ye Q, Zund G, Benedikt P, Jockenhoevel S, Hoerstrup SP, Sakyama S, Hubbell JA, Turina M (2000) Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 17(5):587–591
Lammel AS, Hu X, Park SH, Kaplan DL, Scheibel TR (2010) Controlling silk fibroin particle features for drug delivery. Biomaterials 31(16):4583–4591
Hofmann S, Foo CT, Rossetti F, Textor M, Vunjak-Novakovic G, Kaplan DL, Merkle HP, Meinel L (2006) Silk fibroin as an organic polymer for controlled drug delivery. J Control Release 111(1–2):219–227
Cilurzo F, Gennari CG, Selmin F, Marotta LA, Minghetti P, Montanari L (2011) An investigation into silk fibroin conformation in composite materials intended for drug delivery. Int J Pharm 414(1–2):218–224
Wenk E, Wandrey AJ, Merkle HP, Meinel L (2008) Silk fibroin spheres as a platform for controlled drug delivery. J Control Release 132(1):26–34
Bessa PC, Balmayor ER, Azevedo HS, Nurnberger S, Casal M, van Griensven M, Reis RL, Redl H (2010) Silk fibroin microparticles as carriers for delivery of human recombinant BMPs. Physical characterization and drug release. J Tissue Eng Regen Med 4(5):349–355
Gobin AS, Rhea R, Newman RA, Mathur AB (2006) Silk-fibroin-coated liposomes for long-term and targeted drug delivery. Int J Nanomedicine 1(1):81–87
Bhowmik BB, Sa B, Mukherjee A (2006) Preparation and in vitro characterization of slow release testosterone nanocapsules in alginates. Acta Pharm 56(4):417–429
Dettmar PW, Strugala V, Tselepis C (2007) The effect of alginates on deoxycholic-acid-induced changes in oesophageal mucosal biology at pH 4. J Biomater Sci Polym Ed 18(3):317–333
Varshosaz J (2012) Dextran conjugates in drug delivery. Expert Opin Drug Deliv 9(5):509–523
Liu L, Zheng M, Renette T, Kissel T (2012) Modular synthesis of folate conjugated ternary copolymers: polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate for targeted gene delivery. Bioconjug Chem 23:1211–1220
Varshosaz J, Emami J, Ahmadi F, Tavakoli N, Minaiyan M, Fassihi A, Mahzouni P, Dorkoosh F (2010) Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis. J Drug Target 19(2):140–153
Varshosaz J, Emami J, Fassihi A, Tavakoli N, Minaiyan M, Ahmadi F, Mahzouni P, Dorkoosh F (2010) Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats. Int J Colorectal Dis 25(10):1159–1165
Namkung S, Chu CC (2007) Partially biodegradable temperature- and pH-responsive poly(N-isopropylacrylamide)/dextran-maleic acid hydrogels: formulation and controlled drug delivery of doxorubicin. J Biomater Sci Polym Ed 18(7):901–924
Abdullah S, Wendy-Yeo WY, Hosseinkhani H, Hosseinkhani M, Masrawa E, Ramasamy R, Rosli R, Rahman SA, Domb AJ (2010) Gene transfer into the lung by nanoparticle dextran-spermine/plasmid DNA complexes. J Biomed Biotechnol 2010:284840
Mattioli-Belmonte M, Gigante A, Muzzarelli RA, Politano R, De Benedittis A, Specchia N, Buffa A, Biagini G, Greco F (1999) N,N-dicarboxymethyl chitosan as delivery agent for bone morphogenetic protein in the repair of articular cartilage. Med Biol Eng Comput 37(1):130–134
Trapani A, De Giglio E, Cafagna D, Denora N, Agrimi G, Cassano T, Gaetani S, Cuomo V, Trapani G (2011) Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery. Int J Pharm 419(1–2):296–307
Bhattarai N, Gunn J, Zhang M (2010) Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev 62(1):83–99
Bowman K, Leong KW (2006) Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine 1(2):117–128
Agnihotri SA, Mallikarjuna NN, Aminabhavi TM (2004) Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 100(1):5–28
Alonso MJ, Sanchez A (2003) The potential of chitosan in ocular drug delivery. J Pharm Pharmacol 55(11):1451–1463
Al-Ghananeem AM, Saeed H, Florence R, Yokel RA, Malkawi AH (2010) Intranasal drug delivery of didanosine-loaded chitosan nanoparticles for brain targeting; an attractive route against infections caused by AIDS viruses. J Drug Target 18(5):381–388
Anitha A, Maya S, Deepa N, Chennazhi KP, Nair SV, Jayakumar R (2012) Curcumin-loaded N, O-carboxymethyl chitosan nanoparticles for cancer drug delivery. J Biomater Sci Polym Ed 23:1381–1400
Chen R, Chen Q, Huo D, Ding Y, Hu Y, Jiang X (2012) In situ formation of chitosan-gold hybrid hydrogel and its application for drug delivery. Colloids Surf B Biointerfaces 97:132–137
Chan P, Kurisawa M, Chung JE, Yang YY (2007) Synthesis and characterization of chitosan-g-poly(ethylene glycol)-folate as a non-viral carrier for tumor-targeted gene delivery. Biomaterials 28(3):540–549
Huang W, Shi X, Ren L, Du C, Wang Y (2010) PHBV microspheres–PLGA matrix composite scaffold for bone tissue engineering. Biomaterials 31(15):4278–4285
Ye C, Hu P, Ma MX, Xiang Y, Liu RG, Shang XW (2009) PHB/PHBHHx scaffolds and human adipose-derived stem cells for cartilage tissue engineering. Biomaterials 30(26):4401–4406
Novikova LN, Pettersson J, Brohlin M, Wiberg M, Novikov LN (2008) Biodegradable poly-beta-hydroxybutyrate scaffold seeded with Schwann cells to promote spinal cord repair. Biomaterials 29(9):1198–1206
Falk R, Domb AJ, Polacheck I (1999) A novel injectable water-soluble amphotericin B-arabinogalactan conjugate. Antimicrob Agents Chemother 43(8):1975–1981
Golenser J, Frankenburg S, Ehrenfreund T, Domb AJ (1999) Efficacious treatment of experimental leishmaniasis with amphotericin B-arabinogalactan water-soluble derivatives. Antimicrob Agents Chemother 43(9):2209–2214
Avramoff A, Khan W, Mizrahi B, Domb AJ (2012) Preparation and characterization of a novel once-daily formulation of diltiazem using arabinogalactan as a channeling agent. J Appl Polym Sci 126(S1):E197–E203
Elgart A, Farber S, Domb AJ, Polacheck I, Hoffman A (2010) Polysaccharide pharmacokinetics: amphotericin B arabinogalactan conjugate-a drug delivery system or a new pharmaceutical entity? Biomacromolecules 11(8):1972–1977
Groman EV, Enriquez PM, Jung C, Josephson L (1994) Arabinogalactan for hepatic drug delivery. Bioconjug Chem 5(6):547–556
Gunatillake PA, Adhikari R (2003) Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater 5:1–16, discussion 16
Buchter A, Kleinheinz J, Meyer U, Joos U (2004) Treatment of severe peri-implant bone loss using autogenous bone and a bioabsorbable polymer that delivered doxycycline (Atridox). Br J Oral Maxillofac Surg 42(5):454–456
Sinclair G (2000) The A-X of atridox. Ann R Australas Coll Dent Surg 15:157–158
Wessely R, Kastrati A, Mehilli J, Dibra A, Pache J, Schomig A (2007) Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design. Eur Heart J 28(22):2720–2725
Asbury RF, Brunetto VL, Lee RB, Reid G, Rocereto TF (2002) Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Am J Clin Oncol 25(6):557–560
Matsuura M, Fujiwara T, Kataoka K, Itoh M, Ohtani S, Higaki K, Senoo N (2009) Catamenial pneumothorax with breast cancer treated successfully by goserelin acetate. Kyobu Geka 62(11):1015–1018
Roach M III, Izaguirre A (2007) Goserelin acetate in combination with radiotherapy for prostate cancer. Expert Opin Pharmacother 8(2):257–264
Litjens TT, Fernandez del Moral P, van Laarhoven JP, Weil EH, Debruyne FM (1986) Treatment of advanced prostate carcinoma with a depot form of an LH-RH analog: preliminary endocrinological and clinical results. Ned Tijdschr Geneeskd 130(17):787–790
Sartor O (2003) Eligard: leuprolide acetate in a novel sustained-release delivery system. Urology 61(2 Suppl 1):25–31
Ruiz-Hornillos J, Henriquez-Santana A, Moreno-Fernandez A, Gonzalez IG, Sanchez SR (2009) Systemic allergic dermatitis caused by the solvent of Eligard. Contact Dermatitis 61(6):355–356
Woltering EA, Mamikunian PM, Zietz S, Krutzik SR, Go VL, Vinik AI, Vinik E, O’Dorisio TM, Mamikunian G (2005) Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors. Pancreas 31(4):392–400
Fasano CJ, O’Malley G, Dominici P, Aguilera E, Latta DR (2008) Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia. Ann Emerg Med 51(4):400–406
Brin YS, Golenser J, Mizrahi B, Maoz G, Domb AJ, Peddada S, Tuvia S, Nyska A, Nyska M (2008) Treatment of osteomyelitis in rats by injection of degradable polymer releasing gentamicin. J Control Release 131(2):121–127
Kotler DP, Muurahainen N, Grunfeld C, Wanke C, Thompson M, Saag M, Bock D, Simons G, Gertner JM (2004) Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients. J Acquir Immune Defic Syndr 35(3):239–252
Gefvert O, Eriksson B, Persson P, Helldin L, Bjorner A, Mannaert E, Remmerie B, Eerdekens M, Nyberg S (2005) Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta) in patients with schizophrenia. Int J Neuropsychopharmacol 8(1):27–36
Bobo WV, Shelton RC (2010) Risperidone long-acting injectable (Risperdal Consta(R)) for maintenance treatment in patients with bipolar disorder. Expert Rev Neurother 10(11):1637–1658
Ballabio E, Armesto M, Breeze CE, Manterola L, Arestin M, Tramonti D, Hatton CS, Lawrie CH (2012) Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)? Blood Cancer J 2:e83
Al-Qashi S, Al-Qaoud KM, Ja’fer M, Khali AM (2006) Immunocytogenetic effects of gonadotropin releasing hormone analogue: Triptorelin Pamoate (Decapeptyl) during in vitro fertilization treatment. Hum Exp Toxicol 25(10):593–597
Palatynski A, Gruszczynska J (2001) Decapeptyl (triptorelin) in the treatment of endometriosis genitalis externa. Ginekol Pol 72(5):290–295
Choktanasiri W, Rojanasakul A (2001) Buserelin acetate implants in the treatment of pain in endometriosis. J Med Assoc Thai 84(5):656–660
Harada T, Momoeda M, Taketani Y, Aso T, Fukunaga M, Hagino H, Terakawa N (2009) Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis–a randomized, double-blind, multicenter, controlled trial. Fertil Steril 91(3):675–681
Ory SJ, Hammond CB, Yancy SG, Hendren RW, Pitt CG (1983) The effect of a biodegradable contraceptive capsule (Capronor) containing levonorgestrel on gonadotropin, estrogen, and progesterone levels. Am J Obstet Gynecol 145(5):600–605
Attenello FJ, Mukherjee D, Datoo G, McGirt MJ, Bohan E, Weingart JD, Olivi A, Quinones-Hinojosa A, Brem H (2008) Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol 15(10):2887–2893
Bota DA, Desjardins A, Quinn JA, Affronti ML, Friedman HS (2007) Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas. Ther Clin Risk Manag 3(5):707–715
McGirt MJ, Than KD, Weingart JD, Chaichana KL, Attenello FJ, Olivi A, Laterra J, Kleinberg LR, Grossman SA, Brem H, Quinones-Hinojosa A (2009) Septacin. J Neurosurg 110(3):583–588
Karr J (2008) Utilization of living bilayered cell therapy (Apligraf) for heel ulcers. Adv Skin Wound Care 21(6):270–274
Edmonds M (2009) Apligraf in the treatment of neuropathic diabetic foot ulcers. Int J Low Extrem Wounds 8(1):11–18
Saffarzadeh A, Gauthier O, Bilban M, Bagot D’Arc M, Daculsi G (2009) Comparison of two bone substitute biomaterials consisting of a mixture of fibrin sealant (Tisseel) and MBCP (TricOs) with an autograft in sinus lift surgery in sheep. Clin Oral Implants Res 20(10):1133–1139
Guimard NK, Gomez N, Schmidt CE (2007) Conducting polymers in biomedical engineering. Prog Polym Sci 32(8–9):876–921
Wang YC, Lin MC, Wang DM, Hsieh HJ (2003) Fabrication of a novel porous PGA-chitosan hybrid matrix for tissue engineering. Biomaterials 24(6):1047–1057
Bishara A, Domb AJ (2005) PLA stereocomplexes for controlled release of somatostatin analogue. J Control Release 107(3):474–483
Bunger CM, Grabow N, Sternberg K, Kroger C, Ketner L, Schmitz KP, Kreutzer HJ, Ince H, Nienaber CA, Klar E, Schareck W (2007) Sirolimus-eluting biodegradable poly-L-lactide stent for peripheral vascular application: a preliminary study in porcine carotid arteries. J Surg Res 139(1):77–82
Montjovent MO, Mark S, Mathieu L, Scaletta C, Scherberich A, Delabarde C, Zambelli PY, Bourban PE, Applegate LA, Pioletti DP (2008) Human fetal bone cells associated with ceramic reinforced PLA scaffolds for tissue engineering. Bone 42(3):554–564
Stock UA, Mayer JE Jr (2001) Tissue engineering of cardiac valves on the basis of PGA/PLA Co-polymers. J Long Term Eff Med Implants 11(3–4):249–260
Karp JM, Shoichet MS, Davies JE (2003) Bone formation on two-dimensional poly(DL-lactide-co-glycolide) (PLGA) films and three-dimensional PLGA tissue engineering scaffolds in vitro. J Biomed Mater Res A 64(2):388–396
Kim H, Kim HW, Suh H (2003) Sustained release of ascorbate-2-phosphate and dexamethasone from porous PLGA scaffolds for bone tissue engineering using mesenchymal stem cells. Biomaterials 24(25):4671–4679
Tian JG, Bai DH, Liu ZG, Tang HT, Xia ZF (2003) Experimental studies on the biocompatibility of spongy PLGA-collagen membrane as a tissue-engineering dermal scaffold. Zhonghua Shao Shang Za Zhi 19(Suppl):1–4
Bivas-Benita M, Romeijn S, Junginger HE, Borchard G (2004) PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium. Eur J Pharm Biopharm 58(1):1–6
Csaba N, Caamano P, Sanchez A, Dominguez F, Alonso MJ (2005) PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery. Biomacromolecules 6(1):271–278
Duvvuri S, Janoria KG, Pal D, Mitra AK (2007) Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d, L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. J Ocul Pharmacol Ther 23(3):264–274
Bae SE, Son JS, Park K, Han DK (2009) Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine. J Control Release 133(1):37–43
Chan JM, Zhang L, Yuet KP, Liao G, Rhee JW, Langer R, Farokhzad OC (2009) PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials 30(8):1627–1634
Chen S, Singh J (2008) Controlled release of growth hormone from thermosensitive triblock copolymer systems: in vitro and in vivo evaluation. Int J Pharm 352(1–2):58–65
Danhier F, Vroman B, Lecouturier N, Crokart N, Pourcelle V, Freichels H, Jerome C, Marchand-Brynaert J, Feron O, Preat V (2009) Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. J Control Release 140(2):166–173
Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A (2004) Poly-ε-caprolactone microspheres and nanospheres: an overview. Int J Pharm 278(1):1–23
Byrro RM, Miyashita D, Albuquerque VB, Velasco e Cruz AA, Cunha Junior Ada S (2009) Biodegradable systems containing prednisolone acetate for orbital administration. Arq Bras Oftalmol 72(4):444–450
Kyun KD, Yun KS, Young JS, Pyoung CC, Heui SS (1990) Development of minocycline containing polycaprolactone film as a local drug delivery. Taehan Chikkwa Uisa Hyophoe Chi 28(3):279–290
Hoque ME, Hutmacher DW, Feng W, Li S, Huang MH, Vert M, Wong YS (2005) Fabrication using a rapid prototyping system and in vitro characterization of PEG-PCL-PLA scaffolds for tissue engineering. J Biomater Sci Polym Ed 16(12):1595–1610
Williamson MR, Black R, Kielty C (2006) PCL-PU composite vascular scaffold production for vascular tissue engineering: attachment, proliferation and bioactivity of human vascular endothelial cells. Biomaterials 27(19):3608–3616
Zhao J, Gou M, Dai M, Li X, Cao M, Huang M, Wen Y, Kan B, Qian Z, Wei Y (2009) Preparation, characterization, and in vitro cytotoxicity study of cationic PCL-pluronic-PCL (PCFC) nanoparticles for gene delivery. J Biomed Mater Res A 90(2):506–513
Benagiano G, Gabelnick HL (1979) Biodegradable systems for the sustained release of fertility-regulating agents. J Steroid Biochem 11(1B):449–455
Sokolsky-Papkov M, Agashi K, Olaye A, Shakesheff K, Domb AJ (2007) Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 59(4–5):187–206
Heller J, Barr J, Ng SY, Shen HR, Schwach-Abdellaoui K, Einmahl S, Rothen-Weinhold A, Gurny R (2000) Poly(ortho esters) – their development and some recent applications. Eur J Pharm Biopharm 50(1):121–128
Einmahl S, Behar-Cohen F, Tabatabay C, Savoldelli M, D’Hermies F, Chauvaud D, Heller J, Gurny R (2000) A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular application. J Biomed Mater Res 50(4):566–573
Einmahl S, Zignani M, Varesio E, Heller J, Veuthey JL, Tabatabay C, Gurny R (1999) Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester). Int J Pharm 185(2):189–198
Andriano KP, Daniels AU, Heller J (1992) Biocompatibility and mechanical properties of a totally absorbable composite material for orthopaedic fixation devices. J Appl Biomater 3(3):197–206
Barr J, Woodburn KW, Ng SY, Shen HR, Heller J (2002) Post surgical pain management with poly(ortho esters). Adv Drug Deliv Rev 54(7):1041–1048
Chasin M, Lewis D, Langer R (1988) Polyanhydrides for controlled drug delivery. Biopharm Manuf 1:33–46
Ibim SE, Uhrich KE, Attawia M, Shastri VR, El-Amin SF, Bronson R (1998) Preliminary in vivo report on the osteocompatibility of poly(anhydride-co-imides) evaluated in a tibial model. J Biomed Mater Res 43:374–379
Jain JP, Chitkara D, Kumar N (2008) Polyanhydrides as localized drug delivery carrier: an update. Expert Opin Drug Deliv 5(8):889–907
Jain JP, Modi S, Domb AJ, Kumar N (2005) Role of polyanhydrides as localized drug carriers. J Control Release 103:541–563
Jain JP, Modi S, Kumar N (2008) Hydroxy fatty acid based polyanhydride as drug delivery system: synthesis, characterization, in vitro degradation, drug release, and biocompatibility. J Biomed Mater Res A 84:740–752
Domb AJ (1995) Polymeric carriers for regional drug therapy. Mol Med Today 1(3):134–139
Manoharan C, Singh J (2009) Evaluation of polyanhydride microspheres for basal insulin delivery: effect of copolymer composition and zinc salt on encapsulation, in vitro release, stability, in vivo absorption and bioactivity in diabetic rats. J Pharm Sci 98(11):4237–4250
Shikanov A, Vaisman B, Shikanov S, Domb AJ (2010) Efficacy of poly(sebacic acid-co-ricinoleic acid) biodegradable delivery system for intratumoral delivery of paclitaxel. J Biomed Mater Res A 92(4):1283–1291
Shikanov S, Shikanov A, Gofrit O, Nyska A, Corn B, Domb AJ (2009) Intratumoral delivery of paclitaxel for treatment of orthotopic prostate cancer. J Pharm Sci 98(3):1005–1014
Shikanov A, Domb AJ, Weiniger CF (2007) Long acting local anesthetic-polymer formulation to prolong the effect of analgesia. J Control Release 117(1):97–103
Burkoth AK, Anseth KS (2000) A review of photocrosslinked polyanhydrides: in situ forming degradable networks. Biomaterials 21(23):2395–2404
Jiang HL, Zhu KJ (2000) Pulsatile protein release from a laminated device comprising polyanhydrides and pH-sensitive complexes. Int J Pharm 194(1):51–60
Nair LS, Laurencin CT (2007) Biodegradable polymers as biomaterials. Prog Polym Sci 32(8–9):762–798
Gorna K, Gogolewski S (2002) Biodegradable polyurethanes for implants. II. In vitro degradation and calcification of materials from poly(epsilon-caprolactone)-poly(ethylene oxide) diols and various chain extenders. J Biomed Mater Res 60:592–606
Gunatillake PA, Meijs GF (2008) In: Buschow KHJ, Cahn RW, Flemings MC, Ilschner BI, Kramer EJ, Mahajan S, Veyssière P (eds) Encyclopedia of materials: science and technology. Amsterdam, Elsevier, pp 7746–7752
Bil M, Ryszkowska J, Wozniak P, Kurzydlowski KJ, Lewandowska-Szumiel M (2009) Optimization of the structure of polyurethanes for bone tissue engineering applications. Acta Biomater 6(7):2501–2510
Bonzani IC, Adhikari R, Houshyar S, Mayadunne R, Gunatillake P, Stevens MM (2007) Synthesis of two-component injectable polyurethanes for bone tissue engineering. Biomaterials 28(3):423–433
Jiang X, Wang K, Ding M, Li J, Tan H, Wang Z, Fu Q (2011) Quantitative grafting of peptide onto the nontoxic biodegradable waterborne polyurethanes to fabricate peptide modified scaffold for soft tissue engineering. J Mater Sci Mater Med 22(4):819–827
Cui W, Zhu X, Yang Y, Li X, Jin Y (2009) Evaluation of electrospun fibrous scaffolds of poly(dl-lactide) and poly(ethylene glycol) for skin tissue engineering. Mater Sci Eng C 29:1869–1876
Strehin I, Nahas Z, Arora K, Nguyen T, Elisseeff J (2010) A versatile pH sensitive chondroitin sulfate–PEG tissue adhesive and hydrogel. Biomaterials 31(10):2788–2797
Vashi AV, Keramidaris E, Abberton KM, Morrison WA, Wilson JL, O’Connor AJ, Cooper-White JJ, Thompson EW (2008) Adipose differentiation of bone marrow-derived mesenchymal stem cells using Pluronic F-127 hydrogel in vitro. Biomaterials 29:573–579
Ruszymah BH, Chua K, Latif MA, Hussein FN, Saim AB (2005) Formation of in vivo tissue engineered human hyaline cartilage in the shape of a trachea with internal support. Int J Pediatr Otorhinolaryngol 69:1489–1495
Liu Y, Chen F, Liu W, Cui L, Shang Q, Xia W (2002) Repairing large porcine full-thickness defects of articular cartilage using autologous chondrocyte-engineered cartilage. Tissue Eng 8:709–721
Cortiella J, Nichols JE, Kojima K, Bonassar LJ, Dargon P, Roy AK (2006) Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and Pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth. Tissue Eng 12:1213–1225
Shachaf Y, Gonen-Wadmany M, Seliktar D (2010) The biocompatibility of Pluronic®F127 fibrinogen-based hydrogels. Biomaterials 31(10):2836–2847
Khan W, Muthupandian S, Farah S, Kumar N, Domb AJ (2011) Biodegradable polymers derived from amino acids. Macromol Biosci 11(12):1625–1636
Bourke SL, Kohn J (2003) Polymers derived from the amino acidL-tyrosine:polycarbonates, polyarylates and copolymers with poly(ethylene glycol). Adv Drug Deliv Rev 55:447–466
Gonzalez-Aramundiz JV, Lozano MV, Sousa-Herves A, Fernandez-Megia E, Csaba N (2012) Polypeptides and polyaminoacids in drug delivery. Expert Opin Drug Deliv 9(2):183–201
Cavallaro G, Pitarresi G, Giammona G (2011) Macromolecular prodrugs based on synthetic polyaminoacids: drug delivery and drug targeting in antitumor therapy. Curr Top Med Chem 11(18):2382–2389
Benns JM, Choi JS, Mahato RI, Park JS, Kim SW (2000) pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer. Bioconjug Chem 11(5):637–645
Davis PB, Kowalczyk TH (2010) Preparation and analysis of PEGylated poly-L-lysine DNA nanoparticles for gene delivery. Cold Spring Harb Protoc 2010(5):pdb.prot5419
Holland TA, Tabata Y, Mikos AG (2005) Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 101(1–3):111–125
Peter SJ, Lu L, Kim DJ, Mikos AG (2000) Marrow stromal osteoblast function on a poly(propylene fumarate)/β-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials 21:1207–1213
Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG (1996) In vitro degradation of a poly(propylene fumarate)-based composite materials. Biomaterials 17:2120–2130
Horch RA, Shahid N, Mistry AS, Timmer MD, Mikos AG, Barron AR (2004) Nanoreinforcement of poly(propylene fumarate)-based networks with surface modified alumoxane nanoparticles for bone tissue engineering. Biomacromolecules 5(5):1990–1998
Jabbari E, Wang SF, Lu LC, Gruetzmacher JA, Ameenuddin S, Hefferan TE, Currier BL, Windebank AJ, Yaszemski MJ (2005) Synthesis, material properties, and biocompatibility of a novel self-cross-linkable poly(caprolactone fumarate) as an injectable tissue engineering scaffold. Biomaterials 6:2503–2511
Domb AJ, Laurencin CT, Israeli O, Gerhart TN, Langer R (1990) The formation of propylene fumarate oligomers for use in bioerodible bone cement composites. J Polym Sci A Polym Chem 28:973–985
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Controlled Release Society
About this chapter
Cite this chapter
Khan, W., Challa, V.G.S., Langer, R., Domb, A.J. (2014). Biodegradable Polymers for Focal Delivery Systems. In: Domb, A., Khan, W. (eds) Focal Controlled Drug Delivery. Advances in Delivery Science and Technology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-9434-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9434-8_1
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-9433-1
Online ISBN: 978-1-4614-9434-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)